{"id":"W3199203187","doi":"10.1161/strokeaha.121.035002","title":"Cilostazol for Secondary Stroke Prevention","year":2021,"lang":"en","type":"review","venue":"Stroke","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Alzheimer's Society; National Institute of Nursing Research; National Heart, Lung, and Blood Institute","keywords":"Cilostazol; Medicine; Stroke (engine); Discontinuation; Clopidogrel; Clinical trial; Adverse effect; Aspirin; Randomized controlled trial; Internal medicine; Platelet aggregation inhibitor; Population; Placebo; Antiplatelet drug; Cardiology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007321673,0.0005325728,0.0008654395,0.0009616778,0.0002665328,0.0007280327,0.0003513719,0.000796003,0.01366609],"category_scores_gemma":[0.001388271,0.0001109546,0.0009348316,0.0005517477,0.0002930919,0.0004120193,0.0004861091,0.001810033,0.005908159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005177097,"about_ca_system_score_gemma":0.0008508057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005843413,"about_ca_topic_score_gemma":0.0009183764,"domain_scores_codex":[0.999505,0.0001217773,0.00005003063,0.00007059676,0.0001815129,0.00007103006],"domain_scores_gemma":[0.9995201,0.0001041455,0.0001146246,0.00003601777,0.0001302059,0.00009488539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002526708,0.0005668807,0.0009327767,0.003637822,0.0003087621,0.000458726,0.00004622811,0.0001395934,0.006891812,0.006095257,0.1477702,0.8306252],"study_design_scores_gemma":[0.005713302,0.003853132,0.01029324,0.00328839,0.0006977875,0.003981316,0.0000517434,0.0007393879,0.006678978,0.01114654,0.9534912,0.00006498735],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01318275,0.8682226,0.005774245,0.02573331,0.008742555,0.0004432093,0.001332616,0.0009134201,0.07565531],"genre_scores_gemma":[0.2080004,0.6710886,0.009125392,0.03450594,0.01676263,0.0007762063,0.004842454,0.0001883771,0.05471],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01366609,"threshold_uncertainty_score":0.04571766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04892344570305177,"score_gpt":0.3537345861671592,"score_spread":0.3048111404641075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}